Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

93
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
93
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

287
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
287
Autoimmune Disorders01:29

Autoimmune Disorders

1.2K
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
1.2K
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

155
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
155
Tonsillitis II: Management01:26

Tonsillitis II: Management

278
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
278
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

2.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ancestry-specific rewiring of BCR-MAPK signaling in sarcoidosis B cells.

bioRxiv : the preprint server for biology·2026
Same author

Androgens protect ILC2S from functional suppression during influenza virus infection.

Mucosal immunology·2026
Same author

Aging-associated autoimmunity in genetically diverse UM-HET3 mice shows an early female sex bias.

GeroScience·2026
Same author

ANDROGENS PROTECT ILC2S FROM FUNCTIONAL SUPPRESSION DURING INFLUENZA VIRUS INFECTION.

bioRxiv : the preprint server for biology·2025
Same author

Dysregulated Ca<sup>2+</sup> signaling, fluid secretion, and mitochondrial function in a mouse model of early Sjögren's disease.

eLife·2024
Same author

Deleting Mitochondrial Superoxide Dismutase 2 in Salivary Gland Ductal Epithelial Cells Recapitulates Non-Sjögren's Sicca Syndrome.

International journal of molecular sciences·2024
Same journal

A Comprehensive Experimental Guide to Studying Cross-Presentation in Dendritic Cells In Vitro.

Current protocols in immunology·2020
Same journal

Immunologic Studies in Humans.

Current protocols in immunology·2020
Same journal

Immunologic Studies in Humans.

Current protocols in immunology·2020
Same journal

Immunologic Studies in Humans.

Current protocols in immunology·2020
Same journal

Monoclonal Antibodies to Human Cell Surface Antigens.

Current protocols in immunology·2020
Same journal

Development of a Rapid Focus Reduction Neutralization Test Assay for Measuring SARS-CoV-2 Neutralizing Antibodies.

Current protocols in immunology·2020
See all related articles

Related Experiment Video

Updated: Nov 28, 2025

Author Spotlight: Oral Candida Diagnosis to Advance Clinical Treatment Regimen for pSS Patients
05:26

Author Spotlight: Oral Candida Diagnosis to Advance Clinical Treatment Regimen for pSS Patients

Published on: March 1, 2024

1.6K

Protocols for Experimental Sjögren's Syndrome.

Harini Bagavant1, Umesh S Deshmukh1

  • 1Arthritis and Clinical Immunology, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma.

Current Protocols in Immunology
|November 30, 2020
PubMed
Summary
This summary is machine-generated.

This study explores activating innate immune pathways in mice to understand Sjögren's syndrome (SS) salivary gland issues. Researchers detail methods for assessing gland inflammation, function, and autoantibodies in SS research.

Keywords:
STINGSjögren's syndromeTLR3innate immunitysalivary glands

More Related Videos

Author Spotlight: A Focus on Standardized Salivary Gland Ultrasound Protocol in Connective Tissue Disease Research
07:25

Author Spotlight: A Focus on Standardized Salivary Gland Ultrasound Protocol in Connective Tissue Disease Research

Published on: October 13, 2023

4.2K
A Chronic Autoimmune Dry Eye Rat Model with Increase in Effector Memory T Cells in Eyeball Tissue
09:42

A Chronic Autoimmune Dry Eye Rat Model with Increase in Effector Memory T Cells in Eyeball Tissue

Published on: June 7, 2017

11.8K

Related Experiment Videos

Last Updated: Nov 28, 2025

Author Spotlight: Oral Candida Diagnosis to Advance Clinical Treatment Regimen for pSS Patients
05:26

Author Spotlight: Oral Candida Diagnosis to Advance Clinical Treatment Regimen for pSS Patients

Published on: March 1, 2024

1.6K
Author Spotlight: A Focus on Standardized Salivary Gland Ultrasound Protocol in Connective Tissue Disease Research
07:25

Author Spotlight: A Focus on Standardized Salivary Gland Ultrasound Protocol in Connective Tissue Disease Research

Published on: October 13, 2023

4.2K
A Chronic Autoimmune Dry Eye Rat Model with Increase in Effector Memory T Cells in Eyeball Tissue
09:42

A Chronic Autoimmune Dry Eye Rat Model with Increase in Effector Memory T Cells in Eyeball Tissue

Published on: June 7, 2017

11.8K

Area of Science:

  • Immunology
  • Autoimmune Diseases
  • Pathogenesis Research

Background:

  • Sjögren's syndrome (SS) is a systemic autoimmune disorder primarily affecting salivary and lacrimal glands, leading to dry mouth and eyes.
  • Patients with SS exhibit autoantibodies against nuclear and cytoplasmic antigens, indicating a complex autoimmune response.
  • Innate immune system activation is increasingly recognized as a key factor in the development and progression of SS.

Purpose of the Study:

  • To describe methodologies for activating specific innate immune pathways in a mouse model to study Sjögren's syndrome salivary gland manifestations.
  • To provide detailed protocols for evaluating salivary gland inflammation and function in the context of SS.
  • To outline in-house assay protocols for measuring autoantibody titers in serum for SS research.

Main Methods:

  • Activation of the toll-like receptor 3 (TLR3) pathway in mice to accelerate SS.
  • Induction of SS in mice by activating the stimulator of interferon genes (STING) pathway.
  • Administration of Freund's incomplete adjuvant as an alternate method to accelerate SS.
  • Evaluation of salivary gland function and inflammation using established and in-house assays.
  • Measurement of autoantibody titers via indirect immunofluorescence assays.

Main Results:

  • Specific innate immune pathway activation successfully models SS salivary gland pathology in mice.
  • Protocols enable quantitative assessment of salivary gland inflammation and functional decline.
  • Developed assays allow for reliable measurement of SS-associated autoantibodies.

Conclusions:

  • Innate immune pathway activation provides a robust model for studying SS pathogenesis, particularly salivary gland dysfunction.
  • The described methodologies facilitate comprehensive evaluation of SS in preclinical models.
  • These protocols support further research into the mechanisms and potential therapeutic targets for Sjögren's syndrome.